BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3321400)

  • 21. EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.
    Kuo KH; Khan S; Rand ML; Mian HS; Brnjac E; Sandercock LE; Akula I; Julien JP; Pai EF; Chesney AE
    PLoS One; 2016; 11(3):e0149830. PubMed ID: 26934472
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
    Vaziri ND; Gonzales EC; Wang J; Said S
    Am J Kidney Dis; 1994 Jun; 23(6):828-35. PubMed ID: 8203365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulation and fibrinolysis in pregnancy complicated by intrauterine growth retardation.
    Persson BL; Holmberg L; Astedt B; Nilsson IM
    Acta Obstet Gynecol Scand; 1982; 61(5):455-9. PubMed ID: 7158311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet factor XIII increases the fibrinolytic resistance of platelet-rich clots by accelerating the crosslinking of alpha 2-antiplasmin to fibrin.
    Reed GL; Matsueda GR; Haber E
    Thromb Haemost; 1992 Sep; 68(3):315-20. PubMed ID: 1279832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proteases in blood clotting.
    Walsh PN; Ahmad SS
    Essays Biochem; 2002; 38():95-111. PubMed ID: 12463164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of activated protein C on fibrinolysis in cell-free plasma can be attributed specifically to attenuation of prothrombin activation.
    Bajzar L; Nesheim M
    J Biol Chem; 1993 Apr; 268(12):8608-16. PubMed ID: 8473306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The thrombin activation pathway modulates the assembly, structure and lysis of human plasma clots in vitro.
    Torbet J
    Thromb Haemost; 1995 May; 73(5):785-92. PubMed ID: 7482404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The coagulation and fibrinolysis activities of the blood during various phases of labor].
    Schander K; Wahl W; Rehm A
    Fortschr Med; 1979 Oct; 97(38):1696-702. PubMed ID: 92443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
    Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
    J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood coagulation activation and fibrinolysis during a downhill marathon run.
    Sumann G; Fries D; Griesmacher A; Falkensammer G; Klingler A; Koller A; Streif W; Greie S; Schobersberger B; Schobersberger W
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):435-40. PubMed ID: 17581317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of recombinant activated factor VII on thrombin-mediated feedback activation of coagulation.
    Taketomi T; Szlam F; Bader SO; Sheppard CA; Levy JH; Tanaka KA
    Blood Coagul Fibrinolysis; 2008 Mar; 19(2):135-41. PubMed ID: 18277134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coagulation-fibrinolysis system in poststroke patients receiving antiplatelet medication.
    Tohgi H; Takahashi H; Chiba K; Tamura K
    Stroke; 1993 Jun; 24(6):801-4. PubMed ID: 8506551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reducing thrombin formation during cardiopulmonary bypass: is there a benefit of the additional anticoagulant action of aprotinin?
    Dietrich W
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S50-7. PubMed ID: 8938284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Platelets and coagulation proteins.
    Walsh PN
    Fed Proc; 1981 May; 40(7):2086-91. PubMed ID: 6785110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous measurement of thrombin and plasmin generation to assess the interplay between coagulation and fibrinolysis.
    Matsumoto T; Nogami K; Shima M
    Thromb Haemost; 2013 Oct; 110(4):761-8. PubMed ID: 24072166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris.
    Vaziri ND; Kennedy SC; Kennedy D; Gonzales E
    Am J Med; 1992 Dec; 93(6):651-7. PubMed ID: 1466361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. alpha-Thrombin within fibrin clots: inactivation of thrombin by antithrombin-III.
    Naski MC; Shafer JA
    Thromb Res; 1993 Mar; 69(5):453-65. PubMed ID: 8497860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
    Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
    Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.